Pauli Matias Marttila
Plus aucun poste en cours
Provenance du réseau au premier degré de Pauli Matias Marttila
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 17 | |
Sitra Management Oy
 Sitra Management Oy Investment ManagersFinance Sitra Management Oy (Sitra) is a venture capital subsidiary of the Government of Finland founded in 1967. The firm is headquartered in Helsinki, Finland.
13
| Subsidiary | Investment Managers | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pauli Matias Marttila via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
JSB-Partners LP
 JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Investment Banks/Brokers | Corporate Officer/Principal | |
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
Hapten Sciences, Inc.
 Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Hapten Sciences, Inc. is a biopharmaceutical company. It identifies and develops novel, early-stage products that contribute to the health and well being of people around the world. Its product include PDC-APB, a small molecule that acts like a vaccine to prevent the extremely painful itching and rash. The company was founded by Raymond Joseph Hage Jr. and is headquartered in Memphis, TN. | Pharmaceuticals: Major | Director/Board Member | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Investor | |
| BEIERSDORF | Household/Personal Care | Corporate Officer/Principal | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer | |
| BIOTEST AG | Pharmaceuticals: Other | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
Posti Group Oyj
 Posti Group Oyj Miscellaneous Commercial ServicesCommercial Services Posti Group Oyj provides postal and logistic services. It also offers parcel, freight, and e-commerce solutions. The company was founded by Per Brahe in 1638 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Chairman | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Odewald & Compagnie Gesellschaft für Beteiligungen mbH
 Odewald & Compagnie Gesellschaft für Beteiligungen mbH Investment ManagersFinance Odewald & Compagnie Gesellschaft für Beteiligungen mbH (Odewald) is a private equity firm founded in 1997 by Dr. Jens Odewald. The firm is headquartered in Berlin. | Investment Managers | Corporate Officer/Principal | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Berlin | College/University | Doctorate Degree Doctorate Degree | |
| Aalto University | College/University | Director/Board Member Graduate Degree | |
| University of Helsinki | College/University | Chief Tech/Sci/R&D Officer Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman | |
Corden Pharma SpA
 Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Corden Pharma SpA manufactures sterile liquid dosage forms for injectable use. It offers sterile emulsion technology, pre-filled syringes, distribution of clinical trial medication, and formulation development. The company is headquartered in Caponago, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Oberbergkliniken GmbH
 Oberbergkliniken GmbH Hospital/Nursing ManagementHealth Services Oberbergkliniken GmbH engages in the operation of acute care clinics. It specializes in the medical and psychotherapeutic treatment of patients that suffer from mental, psychosomatic, and psychiatric diseases. The company was founded by Edda Gottschaldt and Matthias Gottschaldt in 1988 and is headquartered in Berlin, Germany. | Hospital/Nursing Management | Chairman | |
Corden Pharma GmbH
 Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Corden Pharma GmbH engages in the development, production, testing, storage, packaging, and distribution of pharmaceutical products. The company was founded on April 14, 2010 and is headquartered in Plankstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
OMOS Equity Partners GmbH
 OMOS Equity Partners GmbH Investment ManagersFinance OMOS Equity Partners GmbH provides investment services. It offers services for major change processes, development and assessment of policy options and scenarios, speech and implementation of transactions, and content solutions. The firm focuses on the health sector, industry sector, and service and logistics sector. The company was founded on July 22, 2014 and is headquartered in Berlin, Germany. | Investment Managers | Chief Executive Officer | |
| Scibase AB | Director/Board Member | ||
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
Heinrich Höpner GmbH & Co. KG
 Heinrich Höpner GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Heinrich Höpner GmbH & Co. KG provides business support services. The private company is based in Hamburg, Germany. The CEOs are Christoph Schröder, Thomas Schröder. The German company was founded in 1913. | Miscellaneous Commercial Services | Chief Executive Officer | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Bluehaven Therapeutics AG | Chief Executive Officer | ||
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Allemagne | 21 |
| Etats-Unis | 12 |
| Royaume-Uni | 6 |
| Finlande | 5 |
| Canada | 3 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 8 |
| Finance | 7 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 103 |
| Corporate Officer/Principal | 41 |
| Chairman | 35 |
| Independent Dir/Board Member | 24 |
| Chief Executive Officer | 22 |
Relations les plus connectées
- Bourse
- Insiders
- Pauli Matias Marttila
- Connexions Sociétés
